Courage Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,050
| Closed | -$231K | – | 35 |
|
|
2021
Q4 | $231K | Hold |
3,050
| – | – | 0.15% | 37 |
|
|
2021
Q3 | $341K | Hold |
3,050
| – | – | 0.18% | 36 |
|
|
2021
Q2 | $494K | Hold |
3,050
| – | – | 0.3% | 32 |
|
|
2021
Q1 | $372K | Hold |
3,050
| – | – | 0.27% | 34 |
|
|
2020
Q4 | $467K | Sell |
3,050
-750
| -20% | -$115K | 0.47% | 25 |
|
|
2020
Q3 | $318K | Hold |
3,800
| – | – | 0.36% | 27 |
|
|
2020
Q2 | $279K | Buy |
+3,800
| New | +$279K | 0.51% | 23 |
|
|
2020
Q1 | – | Sell |
-3,800
| Closed | -$231K | – | 27 |
|
|
2019
Q4 | $231K | Buy |
+3,800
| New | +$231K | 0.7% | 12 |
|
|
2018
Q3 | – | Sell |
-7,200
| Closed | -$423K | – | 22 |
|
|
2018
Q2 | $423K | Sell |
7,200
-900
| -11% | -$52.9K | 0.32% | 17 |
|
|
2018
Q1 | $370K | Hold |
8,100
| – | – | 0.28% | 19 |
|
|
2017
Q4 | $190K | Buy |
+8,100
| New | +$190K | 0.14% | 20 |
|